Malignant neoplasm of spleen
ICD-10 C26.1 is a billable code used to indicate a diagnosis of malignant neoplasm of spleen.
Malignant neoplasm of the spleen, classified under ICD-10 code C26.1, refers to cancerous growths that originate in the splenic tissue. The spleen plays a crucial role in filtering blood and supporting the immune system. Malignancies in this organ can arise from various cell types, including lymphoid tissue, leading to conditions such as splenic lymphoma or secondary involvement from systemic malignancies. Symptoms may include splenomegaly, abdominal pain, fatigue, and unintended weight loss. Diagnosis typically involves imaging studies such as ultrasound or CT scans, along with biopsy for histological confirmation. Treatment options may include surgical intervention, chemotherapy, or radiation therapy, depending on the stage and type of cancer. Accurate coding is essential for proper treatment reimbursement and tracking of cancer incidence, making it vital for coders to understand the nuances of this diagnosis.
Detailed pathology reports, treatment plans, and follow-up notes.
Diagnosis and management of splenic lymphoma, treatment of secondary splenic involvement.
Need for comprehensive staging and treatment documentation to support coding.
Operative reports, pre-operative assessments, and post-operative follow-ups.
Splenectomy for malignant neoplasms, management of splenic abscesses.
Accurate coding of surgical procedures related to splenic malignancies.
Performed for malignant neoplasm of the spleen.
Operative report detailing the indication for surgery and findings.
Ensure that the surgical indication aligns with the diagnosis of C26.1.
Coders need to ensure that pathology reports confirm the malignancy, along with imaging studies that support the diagnosis of malignant neoplasm of the spleen.
